These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 24852077

  • 1. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E.
    Cochrane Database Syst Rev; 2014 May 22; 2014(5):CD004772. PubMed ID: 24852077
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D.
    Cochrane Database Syst Rev; 2012 Jul 11; (7):CD004772. PubMed ID: 22786492
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 4. Optimization of antiretroviral therapy in HIV-infected children under 3 years of age: a systematic review.
    Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams EJ.
    AIDS; 2014 Mar 17; 28 Suppl 2():S137-46. PubMed ID: 24849473
    [Abstract] [Full Text] [Related]

  • 5. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N.
    Cochrane Database Syst Rev; 2016 Dec 10; 12(12):CD004246. PubMed ID: 27943261
    [Abstract] [Full Text] [Related]

  • 6. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouédraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouédraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timité-Konan M, Leroy V, MONOD Study Group.
    BMC Med; 2017 Apr 24; 15(1):85. PubMed ID: 28434406
    [Abstract] [Full Text] [Related]

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 9. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
    Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD008270. PubMed ID: 23740608
    [Abstract] [Full Text] [Related]

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490
    [Abstract] [Full Text] [Related]

  • 11. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
    Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J, OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team.
    PLoS Med; 2012 Jan 24; 9(6):e1001236. PubMed ID: 22719231
    [Abstract] [Full Text] [Related]

  • 12. Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.
    Barlow-Mosha L, Angelidou K, Lindsey J, Archary M, Cotton M, Dittmer S, Fairlie L, Kabugho E, Kamthunzi P, Kinikar A, Mbengeranwa T, Msuya L, Sambo P, Patel K, Barr E, Jean-Phillipe P, Violari A, Mofenson L, Palumbo P, Chi BH.
    Clin Infect Dis; 2016 Oct 15; 63(8):1113-1121. PubMed ID: 27439527
    [Abstract] [Full Text] [Related]

  • 13. Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.
    Shiau S, Kuhn L, Strehlau R, Martens L, McIlleron H, Meredith S, Wiesner L, Coovadia A, Abrams EJ, Arpadi SM.
    BMC Pediatr; 2014 Feb 12; 14():39. PubMed ID: 24521425
    [Abstract] [Full Text] [Related]

  • 14. Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older.
    Alvarez-Uria G, Pakam R, Naik PK, Midde M.
    PLoS One; 2014 Feb 12; 9(9):e108063. PubMed ID: 25232730
    [Abstract] [Full Text] [Related]

  • 15. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, McCarthy N, Morris L, Walker BD, Goulder P.
    AIDS; 2008 Jul 11; 22(11):1333-43. PubMed ID: 18580613
    [Abstract] [Full Text] [Related]

  • 16. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M.
    Cochrane Database Syst Rev; 2013 Oct 10; 10(10):CD010309. PubMed ID: 24114324
    [Abstract] [Full Text] [Related]

  • 17. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.
    Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG, CHER Study Team.
    Lancet; 2013 Nov 09; 382(9904):1555-63. PubMed ID: 24209829
    [Abstract] [Full Text] [Related]

  • 18. Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial.
    Kuhn L, Coovadia A, Strehlau R, Martens L, Hu CC, Meyers T, Sherman G, Hunt G, Persaud D, Morris L, Tsai WY, Abrams EJ.
    Lancet Infect Dis; 2012 Jul 09; 12(7):521-30. PubMed ID: 22424722
    [Abstract] [Full Text] [Related]

  • 19. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.
    Lindsey JC, Hughes MD, Violari A, Eshleman SH, Abrams EJ, Bwakura-Dangarembizi M, Barlow-Mosha L, Kamthunzi P, Sambo PM, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Zimmer B, Petzold E, Mofenson LM, Jean-Philippe P, Palumbo P, P1060 Study Team.
    Pediatr Infect Dis J; 2014 Aug 09; 33(8):846-54. PubMed ID: 25222305
    [Abstract] [Full Text] [Related]

  • 20. Interventions to improve adherence to antiretroviral therapy in children with HIV infection.
    Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.
    Cochrane Database Syst Rev; 2011 Dec 07; 2011(12):CD009513. PubMed ID: 22161452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.